Feb 3, 2026 02:30AM

Oct 1, 2025 07:00AM

Oct 1, 2025 07:00AM

Sep 24, 2025 02:30AM

Jan 13, 2025 02:00AM

Oct 1, 2024 02:00AM

Apr 2, 2024 02:00AM Datopotamab Deruxtecan Biologics License Application Accepted in the U.S. for Patients with Previously Treated Metastatic HR Positive, HER2 Negative Breast Cancer

Feb 19, 2024 02:00AM

Jan 29, 2024 02:00AM

Dec 22, 2023 08:00AM

Apr 20, 2023 09:00PM

Oct 24, 2022 08:00AM

Jul 25, 2022 02:00AM

Apr 19, 2022 02:00AM ENHERTU® Granted Priority Review in the U.S. for Patients with Previously Treated HER2 Mutant Metastatic Non-Small Cell Lung Cancer

14,982 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All